Results 81 to 90 of about 5,954,250 (317)

Enteropathogenic E. coli shows delayed attachment and host response in human jejunum organoid‐derived monolayers compared to HeLa cells

open access: yesFEBS Letters, EarlyView.
Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi   +5 more
wiley   +1 more source

Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases? [PDF]

open access: yes, 2011
Artemisinin-based combination therapy is exerting novel selective pressure upon populations of Plasmodium falciparum across Africa. Levels of resistance to non-artemisinin partner drugs differ among parasite populations, and so the artemisinins are not ...
Mackinnon, Margaret J   +14 more
core   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Frequency of Drug-drug interactions occurred due to multiple drug therapy in BM patients.

open access: yes, 2023
Frequency of Drug-drug interactions occurred due to multiple drug therapy in BM patients.
Shagufta Nesar (13775222)   +6 more
core   +1 more source

Expression and biochemical characterization of a patatin-like medium-chain esterase Rv1063c from Mycobacterium tuberculosis

open access: yesFrontiers in Microbiology
IntroductionMycobacterium tuberculosis is extremely dependent upon lipid-hydrolyzing enzymes to utilize the resources of host lipids and survive within the cell.
Yuming Song   +7 more
doaj   +1 more source

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D

open access: yeseLife, 2019
Vascular endothelial growth factor-C (VEGF-C) acts primarily on endothelial cells, but also on non-vascular targets, for example in the CNS and immune system.
Sawan Kumar Jha   +8 more
doaj   +1 more source

Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats

open access: yesDiabetes & Vascular Disease Research, 2020
Aims: The objective of this study was to explore the effects of epigallocatechin-3-gallate (EGCG) on type 2 diabetes mellitus (T2DM). Main methods: Male Sprague–Dawley rats were allocated into six groups.
Wenru Li   +6 more
doaj   +1 more source

Gut microbiome and aging—A dynamic interplay of microbes, metabolites, and the immune system

open access: yesFEBS Letters, EarlyView.
Age‐dependent shifts in microbial communities engender shifts in microbial metabolite profiles. These in turn drive shifts in barrier surface permeability of the gut and brain and induce immune activation. When paired with preexisting age‐related chronic inflammation this increases the risk of neuroinflammation and neurodegenerative diseases.
Aaron Mehl, Eran Blacher
wiley   +1 more source

Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy

open access: yes
Drug resistance remains a significant barrier to effective cancer therapy. Cancer cells evade treatment by reprogramming their metabolism, switching from glycolysis to oxidative phosphorylation (OXPHOS), and relying on alternative carbon sources such as ...
Irene Kang   +9 more
core   +1 more source

Health-related quality of life measured with K-BILD is associated with survival in patients with idiopathic pulmonary fibrosis

open access: yesBMC Pulmonary Medicine
Background Health-related quality of life (HRQoL) assessments and estimates of prognosis are needed for comprehensive care and planning of subsequent treatment in patients with idiopathic pulmonary fibrosis (IPF).
Tuuli Rautajoki   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy